Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 15.48 M21.32 M — Research & development —— — Operating income -9.16 M-14.5 M — Non-Operating Income, Total 769 K-1.18 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 769 K-338.22 K — Unusual income/expense —-844.73 K — Pretax income -8.39 M-15.69 M — Equity in earnings —— — Taxes 445.93 K66.7 K — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -8.83 M-15.75 M — Discontinued operations —— — Net income -8.83 M-15.75 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 2 M-15.75 M — Basic earnings per share (Basic EPS) —-0.47 — Diluted earnings per share (Diluted EPS) —-0.47 — Average basic shares outstanding —33.74 M — Diluted shares outstanding —33.74 M — EBITDA —— — EBIT —-14.96 M — Cost of revenue —454.59 K — Other cost of goods sold —— — Depreciation & amortization (cash flow) 2.5 M— —